Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns

Table 2 Dataset sample numbers for cancer methylation data.

Tissue Type	Number of Cancer Samples	Number of Normal Samples	Technology
Fackler Breast Tumors	103	21	Infinium 27k
Fang Breast Tumors	39	2	Infinium 27k
Sproul Breast Tumors	34	2	Infinium 27k
Van der Auwera Breast Tumors	62	10	Infinium 27k
Colorectal Tumors	125	29	Infinium 27k
Illingworth Col. Tum.	5	5	MDB-seq
Xu Col. Tum.	6	3	MDB-seq
Berman Col. Tum.	1	1	WG bis-seq
Prostate Tumors	95	86	Infinium 27k
Glioblastomas	88	2	Infinium 27k
Lung Tumors	66	24	Infinium 27k
AMLs	188	8	Infinium 27k
Ovarian Tumors	484	8	Infinium 27k

Details of the number of methylation profiles analyzed for each cancer type. The cancer type, the number of cancer and normal samples analyzed and the technology used to generate the methylation profiles in each case are shown. AMLs, acute myeloid leukemias; Col. Tum, colorectal tumors; Infinium 27k, Illumina infinium Infinium HumanMethylation27 BeadChip array; MBD-seq, Methyl Binding Domain pull-down followed by sequencing; WG bis-seq, whole genome bisulfite sequencing.

ISSN: 1474-760X